MENU
+Compare
TNFA
Stock ticker: NASDAQ
AS OF
May 23, 04:59 PM (EDT)
Price
$0.17
Change
+$0.02 (+13.33%)
Capitalization
2.31M

TNFA TNF Pharmaceuticals Inc. Forecast, Technical & Fundamental Analysis

TNF Pharmaceuticals Inc is a clinical-stage pharmaceutical company committed to extending a healthy lifespan... Show more

TNFA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for TNFA with price predictions
May 22, 2025

Momentum Indicator for TNFA turns negative, indicating new downward trend

TNFA saw its Momentum Indicator move below the 0 level on May 20, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 94 similar instances where the indicator turned negative. In of the 94 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TNFA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for TNFA entered a downward trend on April 30, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where TNFA's RSI Indicator exited the oversold zone, of 33 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Moving Average Convergence Divergence (MACD) for TNFA just turned positive on April 28, 2025. Looking at past instances where TNFA's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where TNFA advanced for three days, in of 218 cases, the price rose further within the following month. The odds of a continued upward trend are .

TNFA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.270) is normal, around the industry mean (16.302). P/E Ratio (0.000) is within average values for comparable stocks, (59.789). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.190). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (277.726).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. TNFA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TNFA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
TNFA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FASDX16.86N/A
N/A
Fidelity Advisor Strategic Div & Inc A
AIOCX9.04N/A
N/A
American Century International Opps C
MCGAX9.78N/A
N/A
Transamerica Mid Cap Growth A
PHLQX39.78N/A
N/A
PGIM Jennison Health Sciences R6
UIVCX11.95N/A
N/A
MFS Intrinsic Value C

TNFA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, TNFA has been loosely correlated with COGT. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if TNFA jumps, then COGT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TNFA
1D Price
Change %
TNFA100%
N/A
COGT - TNFA
39%
Loosely correlated
N/A
PHAT - TNFA
39%
Loosely correlated
N/A
TVGN - TNFA
36%
Loosely correlated
+4.24%
LRMR - TNFA
32%
Poorly correlated
N/A
BPMC - TNFA
29%
Poorly correlated
-1.15%
More